FZD2 and breast cancer: These patterns include elevated Fzd2 in metastatic breast cancer, increased ORAI1 in basal-like breast cancer (BLBC), high expression of Vangl2 and ROR1 in BLBC, and overexpression of Syndecan in BC generally.